Recently, it was found that inhibition of Galectin-1 in tumor cells was related to elevated sensitivity to CDDP in lung cancer, neuroblastoma and epithelial ovarian cancer 36-38. This evidence concerns the gene LGALS1 and ovarian carcinoma.